Market Place
Sourcing Support
Oncohost To Unveil Proteomic Aging Biomarkers Research At AACR
15 Apr 2026 //
PR NEWSWIRE
Oncohost Wins 2026 AI Excellence Award In Health Category
24 Mar 2026 //
PR NEWSWIRE
Oncohost Unveils Breakthrough Study In JPBA On Serum-Plasma
18 Feb 2026 //
PR NEWSWIRE
OncoHost Named Top 10 Small Biz Innovator in 2026 BIG Awards
15 Jan 2026 //
PR NEWSWIRE
Oncohost Wins Gold In 2025 Healthcare Tech Solution Awards
04 Dec 2025 //
PR NEWSWIRE
OncoHost Wins Top Proteomics Award at BioTech Gala
06 Nov 2025 //
PR NEWSWIRE
Oncohost Showcases NSCLC Plasma Proteomics Progress At ISLB 2025
02 Nov 2025 //
PR NEWSWIRE
Oncohost Expands Prophetnsclc® Test Availability With New York
22 Oct 2025 //
PR NEWSWIRE
OncoHost to Present Melanoma Proteomics Data at ESMO 2025
15 Oct 2025 //
PR NEWSWIRE
OncoHost to Present Research on Small Cell Lung Cancer Subtypes
04 Sep 2025 //
PR NEWSWIRE
OncoHost Wins Top Precision Oncology Solution for 2025
30 Jul 2025 //
PR NEWSWIRE
OncoHost Study Reveals Resistance Mechanisms in Lung Cancer
30 May 2025 //
PR NEWSWIRE
OncoHost to Present Three Abstracts at ASCO 2025
27 May 2025 //
PR NEWSWIRE
Onco Host Gets €2.5 M Grant to Advance Precision Oncology
15 May 2025 //
PR NEWSWIRE
OncoHost to Present Plasma Proteomics Research at AACR 2025
23 Apr 2025 //
PR NEWSWIRE
OncoHost partners Gustave Roussy to advance predictive markers
26 Feb 2025 //
PR NEWSWIRE
OncoHost Wins 2025 BIG Innovation Award for Healthcare
15 Jan 2025 //
PR NEWSWIRE
OncoHost Earns CAP Accreditation for Cary Proteomics Lab
03 Dec 2024 //
PR NEWSWIRE
OncoHost Announces Executive Appointment of Ron Andrews
13 Nov 2024 //
PR NEWSWIRE
OncoHost To Present PROphet Renal Cell Carcinoma Data At ESMO 2024
10 Sep 2024 //
PR NEWSWIRE
CVS Health Names Heidi Capozzi Executive Vice President, Chief People Officer
14 Aug 2024 //
PR NEWSWIRE
OncoHost`s PROphetNSCLC Test Influences 93% Of Oncologists` Decisions
29 Jul 2024 //
PR NEWSWIRE
OncoHost Announces New Renal Cell Carcinoma Biomarker Study
02 Jun 2024 //
PR NEWSWIRE
Oncohost Prophet® Application: Multi-Cancer Indications Poster Asco24
23 May 2024 //
PR NEWSWIRE
OncoHost Selected to Present in Oral Minisymposium at AACR
05 Mar 2024 //
PR NEWSWIRE
OncoHost to Present Proteomics-Based Predictive Biomarker
31 Oct 2023 //
PR NEWSWIRE
OncoHost to Present PROphet Biomarker Model that Predicts Clinical Benefit
25 May 2023 //
PR NEWSWIRE
OncoHost Wins 2023 BIG Innovation Award for PROphet® Platform
11 Jan 2023 //
PR NEWSWIRE
OncoHost to Present Proteomics-Based Biomarker Model for Clinical Benefit
07 Nov 2022 //
PRNEWSWIRE
OncoHost Announces New Executive Appointments Ahead of Imminent Launch
03 Oct 2022 //
PRNEWSWIRE
JITC Publishes OncoHost Study on Predictive Proteomic Signature in NSCLC
21 Jun 2022 //
PRNEWSWIRE
SomaLogic licenses protein-diagnostic platform to Israeli biotech firm
14 Jun 2022 //
DAILYCAMERA
OncoHost Raises $35 Million Series C Funding Round
10 May 2022 //
PRNEWSWIRE
OncoHost Collaborates with Roswell Park Comprehensive Cancer Center
05 Apr 2022 //
PRNEWSWIRE
OncoHost Announces Interim Results from PROPHETIC Trial for NSCLC
12 Jan 2022 //
PRNEWSWIRE
OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award
18 Aug 2021 //
PRNEWSWIRE
OncoHost Secures $8 M Series B Funding Round to Advance its AI-Powered Precision
19 Jan 2021 //
PRNEWSWIRE
